Skip to main content
Erschienen in: medizinische genetik 3/2016

28.11.2016 | Präimplantationsdiagnostik | Schwerpunktthema: PID

Präimplantationsdiagnostik – methodische Aspekte

verfasst von: Dr. rer. nat. Andreas Hehr, Bernd Paulmann, Lisa Eichhammer, Claudia Gassner, Bernd Seifert, Ute Hehr

Erschienen in: medizinische genetik | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Präimplantationsdiagnostik erfordert eine enge und vertrauensvolle interdisziplinäre Zusammenarbeit zwischen hoch qualifizierten Fachärzten und Naturwissenschaftlern aus Humangenetik und Reproduktionsmedizin. In einem sehr engen Zeitfenster müssen komplexe Laborabläufe standardisiert und qualitätsgesichert umgesetzt werden. In diesem Beitrag sollen orientierende Empfehlungen zur Umsetzung kurz vorgestellt werden. Zentral haben wir häufigere Problemsituationen thematisiert, welche bereits bei der Indikationsstellung wie auch bei den nachfolgenden Schritten in der genetischen Analyse, Datenauswertung und Befunderstellung mögliche Fehlerquellen darstellen. Ziel unserer verantwortlichen Arbeit an den PID-Zentren sollte eine hohe Geburtenrate bei hoher Diagnosesicherheit mit möglichst wenigen schonenden Behandlungszyklen sein.
Literatur
1.
Zurück zum Zitat De Rycke M, Belva F, Goossens V, Moutou C, SenGupta SB, Traeger-Synodinos J, Coonen E (2015) ESHRE PGD Consortium data collection XIII: Cycles from January to December 2010 with pregnancy follow-up to October 2011. Hum Reprod 30:1763–1789CrossRefPubMed De Rycke M, Belva F, Goossens V, Moutou C, SenGupta SB, Traeger-Synodinos J, Coonen E (2015) ESHRE PGD Consortium data collection XIII: Cycles from January to December 2010 with pregnancy follow-up to October 2011. Hum Reprod 30:1763–1789CrossRefPubMed
2.
Zurück zum Zitat (1990) „Embryonenschutzgesetz vom 13. Dezember 1990 (BGBl. I S. 2746), das zuletzt durch Artikel 1 des Gesetzes vom 21. November 2011 (BGBl. I S. 2228) geändert worden ist“ (1990) „Embryonenschutzgesetz vom 13. Dezember 1990 (BGBl. I S. 2746), das zuletzt durch Artikel 1 des Gesetzes vom 21. November 2011 (BGBl. I S. 2228) geändert worden ist“
3.
Zurück zum Zitat (2013) „Präimplantationsdiagnostikverordnung vom 21. Februar 2013 (BGBl. I S. 323)“ (2013) „Präimplantationsdiagnostikverordnung vom 21. Februar 2013 (BGBl. I S. 323)“
4.
Zurück zum Zitat Harton G, Braude P, Lashwood A, Schmutzler A, Traeger-Synodinos J, Wilton L, Harper JC, European Society for Human Reproduction and Embryology, P.G.D.C. (2011) ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod 26:14–24CrossRefPubMed Harton G, Braude P, Lashwood A, Schmutzler A, Traeger-Synodinos J, Wilton L, Harper JC, European Society for Human Reproduction and Embryology, P.G.D.C. (2011) ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod 26:14–24CrossRefPubMed
5.
Zurück zum Zitat Thornhill AR, deDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, Moutou C, Robinson MD, Schmutzler AG, Scriven PN et al (2005) ESHRE PGD Consortium ‘Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)’. Hum Reprod 20:35–48CrossRefPubMed Thornhill AR, deDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, Moutou C, Robinson MD, Schmutzler AG, Scriven PN et al (2005) ESHRE PGD Consortium ‘Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)’. Hum Reprod 20:35–48CrossRefPubMed
6.
Zurück zum Zitat Preimplantation Genetic Diagnosis International Society (PGDIS) (2008) Guidelines for good practice in PGD: Programme requirements and laboratory quality assurance. Reprod Biomed Online 16:134–147CrossRef Preimplantation Genetic Diagnosis International Society (PGDIS) (2008) Guidelines for good practice in PGD: Programme requirements and laboratory quality assurance. Reprod Biomed Online 16:134–147CrossRef
7.
Zurück zum Zitat Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC, European Society for Human Research and Embryology, P.G.D.C.E.S.I.G. (2011) ESHRE PGD Consortium/Embryology Special Interest Group – best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod 26:41–46CrossRefPubMed Harton GL, Magli MC, Lundin K, Montag M, Lemmen J, Harper JC, European Society for Human Research and Embryology, P.G.D.C.E.S.I.G. (2011) ESHRE PGD Consortium/Embryology Special Interest Group – best practice guidelines for polar body and embryo biopsy for preimplantation genetic diagnosis/screening (PGD/PGS). Hum Reprod 26:41–46CrossRefPubMed
8.
Zurück zum Zitat Harton GL, Harper JC, Coonen E, Pehlivan T, Vesela K, Wilton L, European Society for Human Research and Embryology, P.G.D.C. (2011) ESHRE PGD consortium best practice guidelines for fluorescence in situ hybridization-based PGD. Hum Reprod 26:25–32CrossRefPubMed Harton GL, Harper JC, Coonen E, Pehlivan T, Vesela K, Wilton L, European Society for Human Research and Embryology, P.G.D.C. (2011) ESHRE PGD consortium best practice guidelines for fluorescence in situ hybridization-based PGD. Hum Reprod 26:25–32CrossRefPubMed
9.
Zurück zum Zitat Harton GL, De Rycke M, Fiorentino F, Moutou C, SenGupta S, Traeger-Synodinos J, Harper JC, European Society for Human Research and Embryology, P.G.D.C. (2011) ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod 26:33–40CrossRefPubMed Harton GL, De Rycke M, Fiorentino F, Moutou C, SenGupta S, Traeger-Synodinos J, Harper JC, European Society for Human Research and Embryology, P.G.D.C. (2011) ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod 26:33–40CrossRefPubMed
10.
Zurück zum Zitat Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, Race V, Sistermans E, Sturm M, Weiss M et al (2016) Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet 24:2–5CrossRefPubMed Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, Race V, Sistermans E, Sturm M, Weiss M et al (2016) Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet 24:2–5CrossRefPubMed
11.
Zurück zum Zitat Altarescu G, Beeri R, Lazer-Derbeko G, Eldar-Geva T, Steinberg A, Levy-Lahad E, Renbaum P (2015) Preimplantation genetic risk reduction: A new dilemma in the era of chromosomal microarrays and exome sequencing. Reprod Biomed Online 31:706–710CrossRefPubMed Altarescu G, Beeri R, Lazer-Derbeko G, Eldar-Geva T, Steinberg A, Levy-Lahad E, Renbaum P (2015) Preimplantation genetic risk reduction: A new dilemma in the era of chromosomal microarrays and exome sequencing. Reprod Biomed Online 31:706–710CrossRefPubMed
12.
Zurück zum Zitat Aktuna S (2016) PGD for variants of unknown significance (VUS): perform or not to perform? PGDIS annual meeting Aktuna S (2016) PGD for variants of unknown significance (VUS): perform or not to perform? PGDIS annual meeting
13.
Zurück zum Zitat Lupski JR (2013) Genetics. Genome mosaicism – one human, multiple genomes. Science 341:358–359CrossRefPubMed Lupski JR (2013) Genetics. Genome mosaicism – one human, multiple genomes. Science 341:358–359CrossRefPubMed
14.
Zurück zum Zitat Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL (2005) Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20:402–412CrossRefPubMed Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL (2005) Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20:402–412CrossRefPubMed
15.
Zurück zum Zitat Platteau P, Sermon K, Seneca S, Van Steirteghem A, Devroey P, Liebaers I (2002) Preimplantation genetic diagnosis for fragile Xa syndrome: Difficult but not impossible. Hum Reprod 17:2807–2812CrossRefPubMed Platteau P, Sermon K, Seneca S, Van Steirteghem A, Devroey P, Liebaers I (2002) Preimplantation genetic diagnosis for fragile Xa syndrome: Difficult but not impossible. Hum Reprod 17:2807–2812CrossRefPubMed
16.
Zurück zum Zitat Feyereisen E, Amar A, Kerbrat V, Steffann J, Munnich A, Vekemans M, Frydman R, Frydman N (2006) Myotonic dystrophy: Does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation? Hum Reprod 21:175–182CrossRefPubMed Feyereisen E, Amar A, Kerbrat V, Steffann J, Munnich A, Vekemans M, Frydman R, Frydman N (2006) Myotonic dystrophy: Does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation? Hum Reprod 21:175–182CrossRefPubMed
17.
Zurück zum Zitat Verpoest W, Seneca S, De Rademaeker M, Sermon K, De Rycke M, De Vos M, Haentjens P, Devroey P, Liebaers I (2010) The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract. J Assist Reprod Genet 27:327–333CrossRefPubMedPubMedCentral Verpoest W, Seneca S, De Rademaeker M, Sermon K, De Rycke M, De Vos M, Haentjens P, Devroey P, Liebaers I (2010) The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract. J Assist Reprod Genet 27:327–333CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Drusedau M, Dreesen JC, Derks-Smeets I, Coonen E, van Golde R, van Echten-Arends J, Kastrop PM, Blok MJ, Gomez-Garcia E, Geraedts JP et al (2013) PGD for hereditary breast and ovarian cancer: The route to universal tests for BRCA1 and BRCA2 mutation carriers. Eur J Hum Genet 21:1361–1368CrossRefPubMedPubMedCentral Drusedau M, Dreesen JC, Derks-Smeets I, Coonen E, van Golde R, van Echten-Arends J, Kastrop PM, Blok MJ, Gomez-Garcia E, Geraedts JP et al (2013) PGD for hereditary breast and ovarian cancer: The route to universal tests for BRCA1 and BRCA2 mutation carriers. Eur J Hum Genet 21:1361–1368CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Shen X, Xu Y, Zhong Y, Zhou C, Zeng Y, Zhuang G, Ding C, Li T (2011) Preimplantation genetic diagnosis for alpha-and beta-double thalassemia. J Assist Reprod Genet 28:957–964CrossRefPubMedPubMedCentral Shen X, Xu Y, Zhong Y, Zhou C, Zeng Y, Zhuang G, Ding C, Li T (2011) Preimplantation genetic diagnosis for alpha-and beta-double thalassemia. J Assist Reprod Genet 28:957–964CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Van de Velde H, Georgiou I, De Rycke M, Schots R, Sermon K, Lissens W, Devroey P, Van Steirteghem A, Liebaers I (2004) Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum Reprod 19:700–708CrossRefPubMed Van de Velde H, Georgiou I, De Rycke M, Schots R, Sermon K, Lissens W, Devroey P, Van Steirteghem A, Liebaers I (2004) Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. Hum Reprod 19:700–708CrossRefPubMed
21.
Zurück zum Zitat Wang W, Yap CH, Loh SF, Tan AS, Lim MN, Prasath EB, Chan ML, Tan WC, Jiang B, Yeo GH et al (2010) Simplified PGD of common determinants of haemoglobin Bart’s hydrops fetalis syndrome using multiplex-microsatellite PCR. Reprod Biomed Online 21:642–648CrossRefPubMed Wang W, Yap CH, Loh SF, Tan AS, Lim MN, Prasath EB, Chan ML, Tan WC, Jiang B, Yeo GH et al (2010) Simplified PGD of common determinants of haemoglobin Bart’s hydrops fetalis syndrome using multiplex-microsatellite PCR. Reprod Biomed Online 21:642–648CrossRefPubMed
22.
Zurück zum Zitat Vrettou C, Tzetis M, Traeger-Synodinos J, Palmer G, Kanavakis E (2002) Multiplex sequence variation detection throughout the CFTR gene appropriate for preimplantation genetic diagnosis in populations with heterogeneity of cystic fibrosis mutations. Mol Hum Reprod 8:880–886CrossRefPubMed Vrettou C, Tzetis M, Traeger-Synodinos J, Palmer G, Kanavakis E (2002) Multiplex sequence variation detection throughout the CFTR gene appropriate for preimplantation genetic diagnosis in populations with heterogeneity of cystic fibrosis mutations. Mol Hum Reprod 8:880–886CrossRefPubMed
23.
Zurück zum Zitat Zhang Z, Takeshima Y, Awano H, Nishiyama A, Okizuka Y, Yagi M, Matsuo M (2008) Tandem duplications of two separate fragments of the dystrophin gene in a patient with Duchenne muscular dystrophy. J Hum Genet 53:215–219CrossRefPubMed Zhang Z, Takeshima Y, Awano H, Nishiyama A, Okizuka Y, Yagi M, Matsuo M (2008) Tandem duplications of two separate fragments of the dystrophin gene in a patient with Duchenne muscular dystrophy. J Hum Genet 53:215–219CrossRefPubMed
24.
Zurück zum Zitat Hu XY, Ray PN, Worton RG (1991) Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J 10:2471–2477PubMedPubMedCentral Hu XY, Ray PN, Worton RG (1991) Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J 10:2471–2477PubMedPubMedCentral
25.
Zurück zum Zitat Rechitsky S, Pomerantseva E, Pakhalchuk T, Pauling D, Verlinsky O, Kuliev A (2011) First systematic experience of preimplantation genetic diagnosis for de-novo mutations. Reprod Biomed Online 22:350–361CrossRefPubMed Rechitsky S, Pomerantseva E, Pakhalchuk T, Pauling D, Verlinsky O, Kuliev A (2011) First systematic experience of preimplantation genetic diagnosis for de-novo mutations. Reprod Biomed Online 22:350–361CrossRefPubMed
26.
Zurück zum Zitat Altarescu G, Eldar-Geva T, Varshower I, Brooks B, Haran EZ, Margalioth EJ, Levy-Lahad E, Renbaum P (2009) Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations. Hum Reprod 24:3225–3229CrossRefPubMed Altarescu G, Eldar-Geva T, Varshower I, Brooks B, Haran EZ, Margalioth EJ, Levy-Lahad E, Renbaum P (2009) Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of de novo mutations. Hum Reprod 24:3225–3229CrossRefPubMed
27.
Zurück zum Zitat Altarescu G, Brooks B, Kaplan Y, Eldar-Geva T, Margalioth EJ, Levy-Lahad E, Renbaum P (2006) Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1. Hum Reprod 21:2047–2051CrossRefPubMed Altarescu G, Brooks B, Kaplan Y, Eldar-Geva T, Margalioth EJ, Levy-Lahad E, Renbaum P (2006) Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1. Hum Reprod 21:2047–2051CrossRefPubMed
28.
Zurück zum Zitat Burlet P, Gigarel N, Magen M, Drunat S, Benachi A, Hesters L, Munnich A, Bonnefont JP, Steffann J (2010) Single-sperm analysis for recurrence risk assessment of spinal muscular atrophy. Eur J Hum Genet 18:505–508CrossRefPubMed Burlet P, Gigarel N, Magen M, Drunat S, Benachi A, Hesters L, Munnich A, Bonnefont JP, Steffann J (2010) Single-sperm analysis for recurrence risk assessment of spinal muscular atrophy. Eur J Hum Genet 18:505–508CrossRefPubMed
29.
Zurück zum Zitat Handyside AH (2015) Live births following karyomapping – a „key“ milestone in the development of preimplantation genetic diagnosis. Reprod Biomed Online 31:307–308CrossRefPubMed Handyside AH (2015) Live births following karyomapping – a „key“ milestone in the development of preimplantation genetic diagnosis. Reprod Biomed Online 31:307–308CrossRefPubMed
30.
Zurück zum Zitat Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, Griffin DK (2010) Karyomapping: A universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet 47:651–658CrossRefPubMed Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, Griffin DK (2010) Karyomapping: A universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet 47:651–658CrossRefPubMed
31.
Zurück zum Zitat Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S, Coonen E, Dreesen JC, Stevens SJ, Paulussen AD et al (2014) Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med 16:838–845CrossRefPubMedPubMedCentral Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S, Coonen E, Dreesen JC, Stevens SJ, Paulussen AD et al (2014) Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med 16:838–845CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Thornhill AR, Handyside AH, Ottolini C, Natesan SA, Taylor J, Sage K, Harton G, Cliffe K, Affara N, Konstantinidis M et al (2015) Karyomapping – a comprehensive means of simultaneous monogenic and cytogenetic PGD: Comparison with standard approaches in real time for Marfan syndrome. J Assist Reprod Genet 32:347–356CrossRefPubMedPubMedCentral Thornhill AR, Handyside AH, Ottolini C, Natesan SA, Taylor J, Sage K, Harton G, Cliffe K, Affara N, Konstantinidis M et al (2015) Karyomapping – a comprehensive means of simultaneous monogenic and cytogenetic PGD: Comparison with standard approaches in real time for Marfan syndrome. J Assist Reprod Genet 32:347–356CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Konstantinidis M, Prates R, Goodall NN, Fischer J, Tecson V, Lemma T, Chu B, Jordan A, Armenti E, Wells D et al (2015) Live births following karyomapping of human blastocysts: Experience from clinical application of the method. Reprod Biomed Online 31:394–403CrossRefPubMed Konstantinidis M, Prates R, Goodall NN, Fischer J, Tecson V, Lemma T, Chu B, Jordan A, Armenti E, Wells D et al (2015) Live births following karyomapping of human blastocysts: Experience from clinical application of the method. Reprod Biomed Online 31:394–403CrossRefPubMed
34.
Zurück zum Zitat Tan Y, Yin X, Zhang S, Jiang H, Tan K, Li J, Xiong B, Gong F, Zhang C, Pan X et al (2014) Clinical outcome of preimplantation genetic diagnosis and screening using next generation sequencing. Gigascience. doi:10.1186/2047-217x-3-30 PubMedPubMedCentral Tan Y, Yin X, Zhang S, Jiang H, Tan K, Li J, Xiong B, Gong F, Zhang C, Pan X et al (2014) Clinical outcome of preimplantation genetic diagnosis and screening using next generation sequencing. Gigascience. doi:10.​1186/​2047-217x-3-30 PubMedPubMedCentral
35.
Zurück zum Zitat Lukaszuk K, Pukszta S, Ochman K, Cybulska C, Liss J, Pastuszek E, Zabielska J, Woclawek-Potocka I (2015) Healthy baby born to a Robertsonian translocation carrier following next-generation sequencing-based preimplantation genetic diagnosis: A case report. AJP Rep 5:172–175CrossRef Lukaszuk K, Pukszta S, Ochman K, Cybulska C, Liss J, Pastuszek E, Zabielska J, Woclawek-Potocka I (2015) Healthy baby born to a Robertsonian translocation carrier following next-generation sequencing-based preimplantation genetic diagnosis: A case report. AJP Rep 5:172–175CrossRef
36.
Zurück zum Zitat Zhang W, Liu Y, Wang L, Wang H, Ma M, Xu M, Xu X, Gao Z, Duan J, Cram DS et al (2016) Clinical application of next-generation sequencing in preimplantation genetic diagnosis cycles for Robertsonian and reciprocal translocations. J Assist Reprod Genet 33(7):899–906CrossRefPubMed Zhang W, Liu Y, Wang L, Wang H, Ma M, Xu M, Xu X, Gao Z, Duan J, Cram DS et al (2016) Clinical application of next-generation sequencing in preimplantation genetic diagnosis cycles for Robertsonian and reciprocal translocations. J Assist Reprod Genet 33(7):899–906CrossRefPubMed
37.
Zurück zum Zitat Gianaroli L, Magli MC, Ferraretti AP, Munne S, Balicchia B, Escudero T, Crippa A (2002) Possible interchromosomal effect in embryos generated by gametes from translocation carriers. Hum Reprod 17:3201–3207CrossRefPubMed Gianaroli L, Magli MC, Ferraretti AP, Munne S, Balicchia B, Escudero T, Crippa A (2002) Possible interchromosomal effect in embryos generated by gametes from translocation carriers. Hum Reprod 17:3201–3207CrossRefPubMed
38.
Zurück zum Zitat Pujol A, Durban M, Benet J, Boiso I, Calafell JM, Egozcue J, Navarro J (2003) Multiple aneuploidies in the oocytes of balanced translocation carriers: A preimplantation genetic diagnosis study using first polar body. Reproduction 126:701–711CrossRefPubMed Pujol A, Durban M, Benet J, Boiso I, Calafell JM, Egozcue J, Navarro J (2003) Multiple aneuploidies in the oocytes of balanced translocation carriers: A preimplantation genetic diagnosis study using first polar body. Reproduction 126:701–711CrossRefPubMed
39.
Zurück zum Zitat Harper J, Wells D, Simpson JL (2016) Current controversies in prenatal diagnosis 4: Preimplantation genetic screening should be routinely offered to all preimplantation genetic diagnosis cases. Prenat Diagn 36:25–28CrossRefPubMed Harper J, Wells D, Simpson JL (2016) Current controversies in prenatal diagnosis 4: Preimplantation genetic screening should be routinely offered to all preimplantation genetic diagnosis cases. Prenat Diagn 36:25–28CrossRefPubMed
40.
Zurück zum Zitat van Echten-Arends J, Mastenbroek S, Sikkema-Raddatz B, Korevaar JC, Heineman MJ, van der Veen F, Repping S (2011) Chromosomal mosaicism in human preimplantation embryos: A systematic review. Hum Reprod Update 17:620–627CrossRefPubMed van Echten-Arends J, Mastenbroek S, Sikkema-Raddatz B, Korevaar JC, Heineman MJ, van der Veen F, Repping S (2011) Chromosomal mosaicism in human preimplantation embryos: A systematic review. Hum Reprod Update 17:620–627CrossRefPubMed
41.
Zurück zum Zitat Bolton H, Graham SJ, Van der Aa N, Kumar P, Theunis K, Fernandez Gallardo E, Voet T, Zernicka-Goetz M (2016) Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential. Nat Commun 7:11165. doi:10.1038/ncomms11165 CrossRefPubMedPubMedCentral Bolton H, Graham SJ, Van der Aa N, Kumar P, Theunis K, Fernandez Gallardo E, Voet T, Zernicka-Goetz M (2016) Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal developmental potential. Nat Commun 7:11165. doi:10.​1038/​ncomms11165 CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Greco E, Minasi MG, Fiorentino F (2015) Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med 373:2089–2090CrossRefPubMed Greco E, Minasi MG, Fiorentino F (2015) Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med 373:2089–2090CrossRefPubMed
43.
Zurück zum Zitat Fragouli E, Alfwarawati S, Spath K, Tarozzi N, Borini A, Wells D (2016) The developmental potential of mosaic embryos. PGDIS anuual meeting, Bologna Fragouli E, Alfwarawati S, Spath K, Tarozzi N, Borini A, Wells D (2016) The developmental potential of mosaic embryos. PGDIS anuual meeting, Bologna
44.
Zurück zum Zitat Sermon K, Capalbo A, Cohen J, Coonen E, De Rycke M, De Vos A, Delhanty J, Fiorentino F, Gleicher N, Griesinger G et al (2016) The why, the how and the when of PGS 2.0: Current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Mol Hum Reprod. doi:10.1093/molehr/gaw034 Sermon K, Capalbo A, Cohen J, Coonen E, De Rycke M, De Vos A, Delhanty J, Fiorentino F, Gleicher N, Griesinger G et al (2016) The why, the how and the when of PGS 2.0: Current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Mol Hum Reprod. doi:10.​1093/​molehr/​gaw034
46.
Zurück zum Zitat Brezina PR, Anchan R, Kearns WG (2016) Preimplantation genetic testing for aneuploidy: What technology should you use and what are the differences? J Assist Reprod Genet 33(7):823–832CrossRefPubMed Brezina PR, Anchan R, Kearns WG (2016) Preimplantation genetic testing for aneuploidy: What technology should you use and what are the differences? J Assist Reprod Genet 33(7):823–832CrossRefPubMed
47.
Zurück zum Zitat Treff NR, Fedick A, Tao X, Devkota B, Taylor D, Scott RT Jr. (2013) Evaluation of targeted next-generation sequencing-based preimplantation genetic diagnosis of monogenic disease. Fertil Steril 99:1377–1384 e1376CrossRefPubMed Treff NR, Fedick A, Tao X, Devkota B, Taylor D, Scott RT Jr. (2013) Evaluation of targeted next-generation sequencing-based preimplantation genetic diagnosis of monogenic disease. Fertil Steril 99:1377–1384 e1376CrossRefPubMed
48.
Zurück zum Zitat Wilton L, Thornhill A, Traeger-Synodinos J, Sermon KD, Harper JC (2009) The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod 24:1221–1228CrossRefPubMed Wilton L, Thornhill A, Traeger-Synodinos J, Sermon KD, Harper JC (2009) The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod 24:1221–1228CrossRefPubMed
Metadaten
Titel
Präimplantationsdiagnostik – methodische Aspekte
verfasst von
Dr. rer. nat. Andreas Hehr
Bernd Paulmann
Lisa Eichhammer
Claudia Gassner
Bernd Seifert
Ute Hehr
Publikationsdatum
28.11.2016
Verlag
Springer Medizin
Erschienen in
medizinische genetik / Ausgabe 3/2016
Print ISSN: 0936-5931
Elektronische ISSN: 1863-5490
DOI
https://doi.org/10.1007/s11825-016-0103-5

Weitere Artikel der Ausgabe 3/2016

medizinische genetik 3/2016 Zur Ausgabe

Tagungsbericht Syndromtag 2016

Tagungsbericht Syndromtag 2016

Schwerpunktthema: PID

Präimplantationsdiagnostik

Schwerpunktthema: PID

Fünf Jahre PID-Gesetz

Mitteilungen der GfH

Mitteilungen der GfH